- Home
- NBIX vs PPC Comparison
NBIX vs PPC Comparison
Compare NBIX & PPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBIX
- PPC
- Stock Information
- Founded
- NBIX 1992
- PPC 1946
- Country
- NBIX United States
- PPC United States
- Employees
- NBIX N/A
- PPC N/A
- Industry
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- PPC Meat/Poultry/Fish
- Sector
- NBIX Health Care
- PPC Consumer Staples
- Exchange
- NBIX Nasdaq
- PPC Nasdaq
- Market Cap
- NBIX 12.0B
- PPC 12.5B
- IPO Year
- NBIX 1996
- PPC 1987
- Fundamental
- Price
- NBIX $123.02
- PPC $49.16
- Analyst Decision
- NBIX Strong Buy
- PPC Hold
- Analyst Count
- NBIX 20
- PPC 5
- Target Price
- NBIX $163.20
- PPC $48.40
- AVG Volume (30 Days)
- NBIX 1.6M
- PPC 1.3M
- Earning Date
- NBIX 05-05-2025
- PPC 04-30-2025
- Dividend Yield
- NBIX N/A
- PPC 12.81%
- EPS Growth
- NBIX N/A
- PPC 145.39
- EPS
- NBIX 2.96
- PPC 5.08
- Revenue
- NBIX $2,412,600,000.00
- PPC $17,979,366,000.00
- Revenue This Year
- NBIX $15.99
- PPC $3.31
- Revenue Next Year
- NBIX $14.93
- PPC $1.13
- P/E Ratio
- NBIX $41.60
- PPC $9.68
- Revenue Growth
- NBIX 21.73
- PPC 2.40
- 52 Week Low
- NBIX $84.23
- PPC $33.70
- 52 Week High
- NBIX $157.98
- PPC $57.16
- Technical
- Relative Strength Index (RSI)
- NBIX 62.85
- PPC 49.11
- Support Level
- NBIX $117.59
- PPC $47.64
- Resistance Level
- NBIX $125.63
- PPC $51.45
- Average True Range (ATR)
- NBIX 2.98
- PPC 1.31
- MACD
- NBIX -0.02
- PPC 0.24
- Stochastic Oscillator
- NBIX 72.90
- PPC 60.38
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About PPC Pilgrim's Pride Corporation
Pilgrim's Pride is the second-largest poultry producer in the US (59% of 2024 sales), the UK (29% including other European sales), and Mexico (12%). Its UK and European arm also includes pork operations from the 2019 acquisition of Tulip. Pilgrim's sells to chain restaurants, food processors, food distributors, and retail chains. most of its US and Mexican sales come from fresh chicken, while prepared chicken and pork constitute most of its UK and European sales. JBS owns more than 80% of Pilgrim's Pride's outstanding shares, though it failed to acquire the remaining stake in 2021 after a special board committee deemed JBS' offer undervalued Pilgrim's Pride.